Istituto Gentili Forms Exclusive Partnership with CStone Pharmaceuticals

Deal News | Jul 25, 2025 | Hogan Lovells

Hogan Lovells advised Istituto Gentili on their exclusive partnership with CStone Pharmaceuticals. The advisory team from Hogan Lovells was headed by partner Andrea Pretti, alongside partner Alessandro Seganfreddo and associate Stefania Maracich. On tax-related matters, the team included Head of Tax Serena Pietrosanti, counsel Maria Cristina Conte, and associate Mariateresa Soave Carparelli, who provided expertise on the fiscal aspects of the transaction.

Sectors

  • Pharmaceuticals
  • Legal Advisory

Geography

  • Italy – Istituto Gentili is based in Italy.
  • China – CStone Pharmaceuticals is a biopharmaceutical company based in China, indicating cross-border collaboration.

Industry

  • Pharmaceuticals – The partnership involves two companies within the pharmaceutical industry: Istituto Gentili and CStone Pharmaceuticals.
  • Legal Advisory – Hogan Lovells provided legal and tax advisory services for the partnership agreement.

Financials

    Participants

    NameRoleTypeDescription
    Istituto GentiliTargetCompanyAn Italian-based pharmaceutical company entering an exclusive partnership.
    CStone PharmaceuticalsOther CompanyCompanyA Chinese biopharmaceutical company collaborating with Istituto Gentili.
    Hogan LovellsLegal AdvisorCompanyAn international law firm advising Istituto Gentili on the partnership.
    Andrea PrettiPartnerPersonLed the Hogan Lovells team advising on the transaction.
    Alessandro SeganfreddoPartnerPersonPart of the Hogan Lovells advisory team.
    Stefania MaracichAssociatePersonAssociate at Hogan Lovells involved in the advisory team.
    Serena PietrosantiHead of TaxPersonAdvised on fiscal aspects of the transaction.
    Maria Cristina ConteCounselPersonProvided tax advice for the transaction.
    Mariateresa Soave CarparelliAssociatePersonAdvised on fiscal aspects of the transaction.